Table 2.
Baseline Clinical and Demographic Characteristics
| Patients (N=25) | ||
|---|---|---|
| Characteristics | No. | % |
| Gender | ||
| Female | 12 | 48 |
| Male | 13 | 52 |
| Ethnicity | ||
| White | 23 | 92 |
| Asian | 1 | 4 |
| Native American Indian | 1 | 4 |
| Age, years | ||
| Median | 56 | |
| Range | 26–74 | |
| ECOG performance status | ||
| 0 | 1 | 4 |
| 1 | 22 | 88 |
| 2 | 2 | 8 |
| Primary tumor | ||
| Pancreatic adenocarcinoma | 8 | 32 |
| Non-small cell lung cancer | 6 | 24 |
| Renal cell carcinoma | 2 | 8 |
| Sarcoma | 2 | 8 |
| Others# | 7 | 28 |
| Prior chemotherapy | ||
| 0 | 9 | 36 |
| 1 | 5 | 20 |
| 2 | 8 | 32 |
| ≥3 | 2 | 8 |
| unknown | 1 | 4 |
ECOG: Eastern Cooperative Group
*
one each of adenocarcinoma unknown primary, adenoid cystic carcinoma, ampullary carcinoma, hepatocellular carcinoma, mesothlioma, small cell lung cancer, squamous cell carcinoma ethmoid sinus